^
    No biomarker
    Waldenstrom Macroglobulinemia
    zanubrutinib
    Sensitive
    :
    A1
    No biomarker
    Waldenstrom Macroglobulinemia
    rituximab + ibrutinib
    Sensitive
    :
    A1
    No biomarker
    Waldenstrom Macroglobulinemia
    ibrutinib
    Sensitive
    :
    A1
    No biomarker
    Waldenstrom Macroglobulinemia
    acalabrutinib
    Sensitive
    :
    A2
    No biomarker
    Waldenstrom Macroglobulinemia
    rituximab + ixazomib
    Sensitive
    :
    A2
    No biomarker
    Waldenstrom Macroglobulinemia
    fludarabine oral
    Sensitive
    :
    A2
    No biomarker
    Waldenstrom Macroglobulinemia
    rituximab
    Sensitive
    :
    A2
    No biomarker
    Waldenstrom Macroglobulinemia
    cladribine
    Sensitive
    :
    A2
    No biomarker
    Waldenstrom Macroglobulinemia
    rituximab + bortezomib
    Sensitive
    :
    A2
    No biomarker
    Waldenstrom Macroglobulinemia
    everolimus
    Sensitive
    :
    A2
    No biomarker
    Waldenstrom Macroglobulinemia
    bortezomib
    Sensitive
    :
    A2
    No biomarker
    Waldenstrom Macroglobulinemia
    ofatumumab
    Sensitive
    :
    A2
    No biomarker
    Waldenstrom Macroglobulinemia
    rituximab + carfilzomib
    Sensitive
    :
    A2
    No biomarker
    Waldenstrom Macroglobulinemia
    I-131-CLR1404
    Sensitive
    :
    B
    MYD88 mutation
    Waldenstrom Macroglobulinemia
    ibrutinib
    Sensitive
    :
    C2
    CXCR4 mutation
    Waldenstrom Macroglobulinemia
    ibrutinib
    Sensitive
    :
    C2
    CXCR4 mutation
    Waldenstrom Macroglobulinemia
    rituximab + ixazomib
    Sensitive
    :
    C2
    MYD88 L265P
    Waldenstrom Macroglobulinemia
    rituximab + ixazomib
    Sensitive
    :
    C2
    CXCR4 mutation
    Waldenstrom Macroglobulinemia
    venetoclax
    Sensitive
    :
    C2
    MYD88 mutation + CXCR4 mutation
    Waldenstrom Macroglobulinemia
    ibrutinib
    Sensitive
    :
    C2
    CXCR4 mutation
    Waldenstrom Macroglobulinemia
    BDR
    Sensitive
    :
    C3
    CXCR4 mutation
    Waldenstrom Macroglobulinemia
    rituximab + carfilzomib
    Sensitive
    :
    C3
    CXCR4 G336X
    Waldenstrom Macroglobulinemia
    rituximab + ixazomib
    Sensitive
    :
    C3
    CXCR4 S338X
    Waldenstrom Macroglobulinemia
    rituximab + ixazomib
    Sensitive
    :
    C3
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES